international pharmaceutical industry

www.ipimediaworld.com

Media PlannerInternational Pharmaceutical Industry (IPI) is your Peer-Reviewed, Contemporary & Authoritative guide, focusingon the best - practice in Outsourcing Management for the Pharmaceutical & Bio - Pharmaceutical Companies.

“ IPI is an invaluable publication, providing news

about the latest research and effective insights into

the pharma and bio-pharm markets.

With it’s information editorial content IPI is a great

resource for keeping up to date with the latest

research and regulatory guidelines.”

Suzanne Troop Director, Media Buyer

“The pharmaceutical industry is committed to the research, development, quality manufacturing and logistics of innovativetherapeutic medicines that save lives, reduce overall health care costs and improve the quality of life of people around theworld. The industry strives to create a global environment that fosters innovation in preventing and curing diseases, drugregulation that expedites approvals of new chemical and biological treatments for patients and assures the availability of genuine quality medicines, patient access to innovative therapies and protection from substandard and counterfeit products,mamarket-based competition in the health care sector, and the dissemination of drug information and ethical promotion of drugs to medical professionals and, where legal, to patients.” IFPMA

“Supporting The Industry Through Communication”

In order to achieve this objective, it is essential for the executives of this dynamic industry to constantly keep themselves educated in the latest technology, market information, regulatory and validatory guidelines to gain a competitive edge. IPI provides a peer reviewed platform addressing the entire outsourcing industry and management, thus meeting this demand. Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industries. Dindustries. Detailing the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable all stakeholders to become more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.

Why Advertise with IPI?

International Pharmaceutical Industry is a globallydistributed publication with an established presence across the World.

Each quarterly issue has a hard-copy distributionfigure of 20,000 copies, providing strong access to the International Market.

Europe: 8,435USA & Canada: 6,442ROW: 5,126Distrubution by Job Function Subsection in the Industry

International Pharmaceutical Industry Journalis sent directly to key decision makers in the life science industry addressing all stakeholders

87% of our subscribers read or look through IPI within one week of receiving their copy

83.6% of our subscribers would beextremely or very likely to refer IPI to a colleague orco-worker.

IPI is the only peer reviewed journal which, looks into the effective management of the entire pharmaceutical & biopharmaceutical Outsourcingindustry.

Detailing the latest in Research & Technologyinnovations, Drug Discovery Platforms,Contract Manufacturing & Contract Manufacturing & Packaging services, Regulatory Guidelines, Marketing & Communication strategies. IPI helps todaysLife Sciences executive to stay abreast of thelatest information, helping them to make efficientand cost effective decisions.

43.2% Pharmaceutical/ Bio-Pharmaceutical Companies7.0 % Fine Chemical Companies 11.2% Contract Manufacturing Companies 8.0% Analytical/ Biochemical Laboratories6.5% Contract Packers 77.1% CRO6.0% Health Services4.0% Others- including speciality pharma, drug (discovery, development & delivery) consultants,financial institution & government Bodies

8% CEO/ CFO/ CMO7% Medical Directors 9% Heads of Operations 9% Heads of Packaging Management 8% Heads of Procurement7% Clinicians 9% Heads of 9% Heads of Research & Development 7% Heads of Production 8% Heads of Formulation Development 7% Heads of Clinical Trials 5% Logistics and Supply Chain Managers4% Heads of Business Development/ Sales and Marketing 4% Brand/ Production Manager 4% Brand/ Production Manager 4% Heads of Regulatory Affairs

Reader’s Perspective83 % of subscribers have renewed subscription year on year81 % of subscribers have read the last 4 issues

62 % of subscribers have kept copies of IPI

for future references

11 % of subscribe11 % of subscribers corrospond with authors

3.2 % new subsciption every year

Author’s Perspective 76 % of authors have submitted furtherarticles in IPI61 % Have requested reprints

44 % Had their article downloaded in PDF

29 % Had their article searched by name

on IPI on IPI website

16 % Impact factor

Advertiser’s Perspective89 % of advertisers have repeated advertisments in IPI85 % Have utilised IPI online services

81 % Have advertised every consecutive year

62 % of advertisers chose JCS above other

industindustry publications

8 % Have requested bespoke distrubution

Circulation Profile

We work with the best in the industry to provide our readerswith valuable, upto date infomation on the Life Science Sector

Abbot EISAI One World Health Akzo Nobel Lilly & Co PfizerAmgen Genetech Rapid Health AsAstellas Genzyme Recipharm AstraZeneca GSK Registrat- Mapi Bayer Schering AG Imclone Sanbe PharmaBiogen Johnson & Johnson Sanofi- AventisBoehhringer- Ingelheim Mex Neeman Schering PloughBMS Medimune SofrigamCentocor Merck KGA Swiss PharmaDaiDaichi Sankyo Millenium QualogyDabur Novartis World Courier Dr. Reddys Nova Nordisk Zinsser Analytic

Companies Companies Companies

Companies Accessed

Today, the outsourcing industry is all the buzz. This section looks at custom and contract manufacturing starting from fine chemicals, active ingredients into dosage forms and delivery device productions

Manufacturing

Packaging

The Labs Section Looks into analytical technologies, Laboratory Equipment, InformationManagement systems. The logistics section incorporates Supply Chain Management, Clinical Trials Supply and Temperature ControlledLogistics

Labs, Logistics, Cold Chain Supply

This section offers information on services in bothcontract and clinical research. This sectionlooks into all aspects of activities from PK/PD studies to Late Phase Trials. It look into choosingthe right CRO,Trial Design, Patient Recruitement & Retention,Site Management, Data Capture, Analysis and Submission. Analysis and Submission.

Clinical Research

This section focuses on drug platforms, proteinidentification, chemical entities and alike. Fromdiscovery to development, we work with all thosein this important ‘first’ step, including researchand technologies on how a drug is best delivered.

Drug Discovery,Development & Delivery

This section incorporates information on legal, consulting, regulatory initiatives and promotional opportunities for centralised life science organisation. we will bring you information on various life sciences cluster, regional and countryspecific information about Life- Sciences inninnovation and market operations.

Regulatory & Market Place

International Pharmaceutical industry is divided into six sections, incorporating the entire valure chain of the pharmaceutical outsourcing industry.

Preparing the product for the end user is so important to today’s consumer. Packaging plays a vital role in brand identity and patientengagement. Anti- Counterfeiting, producttracking, brand protection Braille, and tamper reisistant technologies are all discussed here.

Subjects Covered in JCS * Primary Manufacturing: API, Fine Chemicals, Formulations, Excipients * Drug Discovery, Delivery & Therapeutics * Biopharmaceutical Contract Manufacturing - Cell Culture, Fermentatoin, biological API, Genomics and Proteomics * Outsourcing and Contract Manufacturing _ validation - GCP, GLP comploance, quality control and quality assurance * Investigation Medicinal Products, Clinical Trial Materials Managements * Clinical Research - Patient Recruitement & Retention IVRS, EDC, ePRO * Therapeutic Studies * Contract Research, Drug Discovery & Development * Drug Delivery Technology & Dosage form Production * Clean Room Technology * Six Sigma Compliance, PAT, ERP * Innovations, Machineries, Technology * Maintenence, Life Cycle Management * Primary & Secondary Packing and Packaging * Logistics & Supply Chain, Temperature Controlled Logistics. Storage & Warehouse * Anti-counterfeiting, and Brand Protection (RFID, Pigmentation, covert and overt Technology) * Patient Information, and DTC marketing * Physician & Health worker communication

Therapeutic Areas Covered * Oncology * CNS * Cardiovascular * Infectious Diseases * Dermatology * Liver Diseases * Kidney Diseases * Ophthalmology * Immunology/ Haematology * Respiratory * Orthopaedic * Pain * Geriatric * Gastroenterology * Pathology * Pediatric * Women’s Health * HIV/AIDS * Vaccine - Preventable Diseases * Malaria * Malnutrition & Under Nutrition * Tropical * Diseases * Reproductive

Editorial Topics and Focal Areas

Logo & News £600 for 3 Months

Banner £500 for 3 months

Company Profile listing:700-800 words of your services + CompanyLogo, directed to your website

Email BlastNews from your company on our newsletter, that goes to 9,000 opted-in subscibers.

E-E-NewsletterIPI E- Newsletter comprises of latest news from the global clinical research industry. It also contains links to various articles which we have published in the journal. This is an ideal way for executives in the industry to keep abreast of the latest happenings in this fast mhappenings in this fast moving clinical research environment. The E-Newsletter goes out in a HTML format straight intosubscribers inbox.

Video Hosted on our wesbite for £700, for 3 months

Online Services

Pharma Publications, Tel: +44(0)207 237 2036, Fax: +44(0)208 579 2036, Email: [email protected], Tower Bridge Business Complex,Building J, Unit- 413,100 clement road, London, SE16 4DG

£5,950

£2850

£1,650

£1650

Front Cover Logo: £1,500Inside Front Cover: £5,950Inside BaInside Back Cover:̀ £4,850Outside Back Cover: £7,250Next to Editor’s Letter: £3,750Next to Contents Page: £3,750

Advertising RatesHard Copy & E-JournalDouble Page

Full Page

Half Page Horizontal

Half Page Vertical

Special Position

Page Layout Design

International Pharmaceutical Industry provides print advertisiments and a package of online services, dedicated to assist you with your marketing campaign.

Rate Card & Promotional Services

Mechanical Specification

Purchasing Power 90.7% of IPI readers are involved in thedecision of purchasing products and

services for thier company.

Reprographic Mechanical Details(In Millimetres, Height x Width, withType, Trim, Bleed)DPS:

273x396 (Type) 297x420 (Trim) 303x426 (Bleed)

FULL PAGE:


½ PAGE HORIZONTAL:


½ PAGE VERTICLE:


¼ PAGE:

135x90 (Type)

ElectElectronic pictures or graphics can be supplied in the following formats:1. Adobe Photoshop TIFF (*.tiff), JPEG, PDF or EPS2. Adobe Illustrator EPSElectronic images/graphics must be supplied at highresolution (at least 300dpi)Electronic images/graphics should be in CMYK colour.Please do nPlease do not send files embedded in Microsoft WordDocuments. Please supply them as separateattachments.

Client designed adverts should be supplied in one of the following ways:1. Adobe Illustrator CS2, Images and Graphics must be embedded. Fonts should be supplied if they are nnot embedded/converted to outline.2. Adobe Acrobat PDF. Advert PDF must be supplied optimised for high quality printing. All colours (inc. pictures) must be CMYK, no RGB or Pantone.They must include high resolution graphics (300dpi)and embedded fonts. Bleed adverts must include registration markings and bleed. We are unable to mamake amendments to PDF files.

58.1% Recommended and influences, purchasing

21.3% Key Decision Makers

9.3% Readers not involved in purchasing decisions

11.3% Make decisions as

groups

.

Exhibitions & Conferences Attended by IPI with this issue:

> DIA Euro Meeting > Interphex Chicago > BIO Trinity 2013 > BIO USA > 22

nd Partnership in > Pharmintech (Italy)

Clinical Trials (USA) > Knowledge for Growth (ICC Ghent) > BIO Europe Spring

Volume 5 Issue 1 – February 2013 Submission deadline – 15th January 2013

Regulatory & Marketplace

> Intellectual Property & Patent Law > Pharmacovigilance / Legislation > Clinic to Commercialization > Quality Assurance / Quality Control > Child resistant packaging policies > Audience Segmentation: Personalized Marketing > eCTD Regulations > Market Access Strategies

Drug Discovery / Delivery & Therapeutics

> Improving Antibody Efficacy > Oral Drug Delivery > Stem Cells in Therapeutics > Formulation & Excipients > Fragment Based Drug Design > Pulmonary Drug Delivery > Injectable Pens & Self Injection > Biologics & Therapeutics > Smart Pill technology

Clinical & Medical Research

> Ethics Committee & Review Boards > Adaptive Clinical Trials – Personalised Medicine > Biomarkers > Clinical Patient Recruitment

> Data Management > Late Stage Research (Phase II – IV)

Clinical Trials

> Patient Recruitment & Retention > Adaptive Clinical Trials > CTS / CTMS > Pharmacokinetics (PK Studies) > Biodynamic > Named Patient Programme > Therapeutic Vaccine

Labs & Logistics

> Imaging, ECG & Core Labs > CAP Accreditation > Temperature Controlled Logistics > Analytical Labs & Testing > LIMS > Cool / Cold Chain > Margins & Operating Efficiencies

Manufacturing

> Dosage Form Production > Lean Manufacturing / Six Sigma

Solids > PAT

Capsules > Tooling > Aseptic Processing > Pure Water / WFI > Clean Room & Contamination Control > Peptide Synthesis > Pre-formulation

Packaging

> Patient Adherence Packaging > Braille Packaging > Child resistant & Senior Friendly > Sterile Packaging / Sterile Closures > IV Bags & Delivery Systems > Moisture Barrier

IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com web-site for Peer Review Protocol and Authors Guidelines.

http://www.ipimediaworld.com/


> 49

th DIA Annual Meeting > Process & Packaging Machine

> Cool Chain IQPC (USA) > CDISC International Interchange

> World Stem Cell & Regenerative Medicine 2013 > BIO (BOSTON) > EPIC

Volume 5 Issue 2 – May 2013 Submission deadline – 15th April 2013


> Quality Assurance / Quality Control > lDTC Marketing > FDA Bio Research Monitoring > Programme – Protecting Human Subjects > FDA/EMA / WHO – Validation & Accreditation > Intellectual Property > Insurance & Liabilities


> Antibody Drugs for Oncology > Molecular Technology > Parenteral > Nano Technology > Custom Antibodies > Drug Implants > In vivo / In vitro > Women’s Health > Prefilled Injection Systems > Tableting (New Tablet Press generation)


> Preclinical > PK / PD Studies > Imaging Technology > EDC / ePRO

> IVRS / IWRS / IXRS > Physician Liability & Ethics Review > Phase 1 / Early Stage > Cancer / Immunotherapy (Development of Monoclonal

Antibodies)

Clinical Trials

> Managing Adverse Reactions > eClinical Solutions > Patient Safety & Clinical Monitoring > CDISC > Comparator Drug Supply > ABPI New Guidelines on Phase 1 Clinical Trials

Labs & Logistics

> Imaging & Data Collection > Cool Chain & Cold Chain > IVRS / IWRS / IXRS > E – Procurement > Hazardous Cargo > Temperature Controlled Supply Chain

Manufacturing

> Pre Filled Syringes / Self Injections > Raw Materials > Ingredients & Intermediates > Sterile Fill Finish > Blow Fill Seal Technology > Lyophilisation & Freeze Drying > Containment Technology > TOC / HPLC > Softgel Technology > The Suitability of Formulations for specific

Pharmaceutical Applications

Packaging

> Stability Testing & Shelf Life Management > Moisture Absorption & Moisture Barrier > Anti-Counterfeiting & Brand Protection > RFID Coding & Marking > Clinical Trials Packaging > Patient Information

The topics and subjects listed above are special fea-tures and focuses. Please refer to the media infor-mation for a list of general topics that will be featured in IPI throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – [email protected] Current News and Press Releases can also emailed to the above email address and will be hosted at – www.jforcs.com, or featured in the JCS Weekly News-letter at our discretion.

mailto:[email protected]

http://www.jforcs.com/


> CPHI / ICSE / PMEC / BIOPH 2013 (Frankfurt) > BIO EUROPE – Autumn > BIO Partnering Future Europe > Partnership in Clinical Trials Europe > Scanbalt 2013

Volume 5 Issue 3 – August 2013 Submission deadline – 15th July 2013


> ICH Regulations on Monitoring > Period on New Drugs > Health Economics > ICH – GCP Guidelines > Patent Law > Insurance > Epidemiology


> Toxicity Assays > Inhalation & Nasal Drug Delivery – MDI’s & DPI’s > Diabetes > Advances in Stem Cell Technology > Imaging Technologies (Safety & Testing) > Cardiovascular / Metabolic > Biopharmaceutical Lab Services > Supporting Drug Safety


> Medical Imaging > eCTD > Bio Equivalence Studies > Medical Devices > SMO/ Site Management > Pharmacovigilance & Drug Safety > Human Embryonic Stem Cells (hESCo)

Clinical Trials

> Cardiovascular Safety / QTc Prolongation > CTS/CTMS > Rescue Studies > CDISC/CDASH > Hepatic & Renal Impairment > Targeted Populations

Labs & Logistics

> Global Central Laboratories > Cardiology > Safety Testing > Time Sensitive Shipment > RFID Tracking Systems > Optical Sensing > Emerging Markets Customs

Manufacturing

> Parenteral > Semi Solids / Creams & Ointments > Neutraceuticals > Topical > IV Drug Delivery > Robotics & CAM > Filtration & Separation > Prefilled Injectable > Inhalation

Packaging

> Labelling & Bar-coding > Patient Information Leafleting > Translation & License Regulation > Electronic Notification & Intelligent Packaging

– to enhance patient compliance > Booklet Labelling > Authentication & Brand Protection

IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com web-site for Peer Review Protocol and Authors Guidelines.

http://www.ipimediaworld.com/

Exhibitions & Conferences Attended by IPI with this issue: > IQPC Cool Chain 2013 > ICSE / CPHI / BIOPH / PMEC India > Genesis > BIO Partnering (Brussels)

Volume 5 Issue 4 – November 2013 Submission deadline – 15th October 2013


> FDA / EMEA / WHO – > Helsinki Declaration – > Validation & Accreditation what it means in the current climate. > Vaccines & Adjuvant – Prevention & Cure > Cardiovascular Safety > FDA/EMA Submission Policies


> Antibody Drugs for Oncology > Parenterals > Cell Processing Tools > Fragment Based Drug Design > Custom Antibodies > Transdermal > Prefilled Injection Systems > CNS – Alzheimer’s > Cognitive Research


> Managing Adverse Reactions > Phase I – IV > Preclinical > PharmacoEconomics > IMP Manufacturing & Supply > Medical Imaging

Clinical Trials

> Imaging in Oncology > Lab Validation > Temperature Controlled / Data logging > LIMS in Clinical Trials Shipment > Central, Global, Analytical Labs

Labs & Logistics

> Lab Validation > Imaging in Oncology > Temperature Controlled/Data Logging > LIMS in Clinical Trials Shipment

Manufacturing

> Leak Detection & Vision System > Quality Control & Quality Assurance > FDA & EMEA Facility Compliance > Environmental Protection & Facility Management > Solid Dosage Form production > Raman Spectroscopy > Filtration & Milling > Blending & Mixing Technologies

Packaging

> Liquids & Sachets > Blistering & De-Blistering Machines > Brand Protection > Sterile Fill Finish > Prefilled Injection Systems > RFID Coding & Marking > Clinical Trials Packaging

The topics and subjects listed above are special features and focuses. Please refer to the media information for a list of general topics that will be featured in IPI throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – [email protected] Current News and Press Releases can also emailed to the above email address and will be hosted at – www.jforcs.com, or featured in the JCS Weekly News-letter at our discretion.

mailto:[email protected]

http://www.jforcs.com/

A fresh and dynamic organisaon dedicated to the lifescience Industry. A Winning Combinaon... ‘Going for Gold’

Pharma Publicaons, Tower Bridge Business Complex, London SE16 4DG, Tel: +44(0)207 237 2036, Email: [email protected]

www.jforcs.com

www.jforpc.com

www.ipimedia.com